Improving the lives of people living with epilepsy

The Australian Epilepsy Project (AEP) was awarded $30m from the Medical Research Future Fund Frontiers Program in 2021, the largest single government investment into epilepsy research in Australia, to design and deliver a brain-health platform that will change the standard of care in epilepsy by solving the three core issues of access, uncertainty, and cost.

Cutting edge AI technology combines and analyses multimodal patient information to highlight critical diagnostic and treatment information. The platform is a national solution that already connects over 1,600 patients with over 160 neurologists across all mainland states. The AEP translates and extends over 30 years of Florey research in imaging, genetics and psychology into patient outcomes positively impacting the lives of many Australians living with or recently diagnosed with epilepsy.

The AEP is a working example of how AI and technology can be used to develop a scalable expert system, that enables a better standard of care for complex conditions, and is delivering real world results including a 10% improved epilepsy-causing lesion detection, 8% improved quality of life (over the two years of follow-up), 9% improved work productivity (for those with epilepsy related reduced working hours) and an 8% average reduction of seizure rates across all cohorts.

We are passionate about improving the lives of people experiencing seizures and have a dedicated team working on reducing the burden on people living with epilepsy.


Epilepsy is just the beginning...‍
The AEP is designed to be a platform model for brain healthcare and research.  Epilepsy is a whole of brain disease. We need to understand genetic risks, structural make-up and functioning to identify causes and predict intervention outcomes. This is highly applicable to other brain health issues such as dementia,concussion, and mental health.